Rapid induction of Alzheimer A beta amyloid formation by zinc

Bush, A., Pettingell, W., Multhaup, G, d Paradis, M, Vonsattel, J., Gusella, J., Beyreuther, K, Masters, C. +1 more·1994·Science
DOI 10.1126/science.8073293

Cited by (1,001)

Items 101–200 of 1,001

  1. Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues
    Davide Brambilla, Benjamin Le Droumaguet, Julien Nicolas, Sayed Hossein Hashemi, Linping Wu, Seyed Moein Moghimi, Patrick Couvreur, Karine Andrieux · 2011 · Nanomedicine Nanotechnology Biology and Medicine
  2. Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β
    Craig Atwood, Mark E. Obrenovich, Tianbing Liu, Hsien Chan, George L. Perry, Mark A. Smith, Ralph Nigel Martins · 2003 · Brain Research Reviews
  3. The amyloid cascade hypothesis: an updated critical review
    Kasper P. Kepp, Nikolaos K. R K Robakis, Poul Flemming Høilund‐Carlsen, Stefano Luca Sensi, Bryce Vissel · 2023 · Brain
  4. Zinc homeostasis and neurodegenerative disorders
    Szewczyk, Bernadeta · 2013 · Frontiers in Aging Neuroscience
  5. Polymorphism in Alzheimer Aβ Amyloid Organization Reflects Conformational Selection in a Rugged Energy Landscape
    Yifat Miller, Buyong Ma, Ruth Nussinov · 2010 · Chemical Reviews
  6. Copper and Zinc Dysregulation in Alzheimer’s Disease
    Stefano Luca Sensi, Alberto Granzotto, Mariacristina Siotto, Rosanna Squitti · 2018 · Trends in Pharmacological Sciences
  7. Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics
    James A. Duce, Ashley Ian Bush · 2010 · Progress in Neurobiology
  8. Brain, aging and neurodegeneration: Role of zinc ion availability
    Eugenio Mocchegiani, Carlo Bertoni–Freddari, Fiorella Marcellini, Marco Malavolta · 2005 · Progress in Neurobiology
  9. Structural and kinetic features of amyloid β-protein fibrillogenesis
    David B. Teplow · 1998 · Amyloid
  10. AIE-based luminescence probes for metal ion detection
    Parvej Alam, Nelson L. C. Leung, Jing Zhang, Ryan T. K. Kwok, Jacky W. Y. Lam, Ben Zhong Tang · 2020 · Coordination Chemistry Reviews
  11. Elevated cortical zinc in Alzheimer disease
    Dorota Religa, D. Strozyk, Robert A. Cherny, Irene Volitakis, Varham Haroutunian, Bengt G. Winblad, Jan Näslund, Ashley Ian Bush · 2006 · Neurology
  12. The ACAT Inhibitor CP-113,818 Markedly Reduces Amyloid Pathology in a Mouse Model of Alzheimer's Disease
    Birgit Hutter‐Paier, Henri J. Huttunen, Luigi Puglielli, Christopher B. Eckman, Doo Yeon Kim, Alexander Hofmeister, Robert D. Moir, Sarah B. Domnitz, Matthew P. Frosch, Manfred Windisch et al. · 2004 · Neuron
  13. Photoluminescence imaging of Zn 2+ in living systems
    Yuncong Chen, Bai Yang, Zhong Han, Weijiang He, Zijian Guo · 2015 · Chemical Society Reviews
  14. The role of metallobiology and amyloid-β peptides in Alzheimer's disease
    Roberts, Blaine R., Ryan, Timothy M., Bush, Ashley I., Masters, Colin L., Duce, James A. · 2012 · Journal of Neurochemistry
  15. Iron, zinc and copper in the Alzheimer's disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion
    Matthew Schrag, Claudius Mueller, Udochukwu E. Oyoyo, Mark A. Smith, Wolff M. Kirsch · 2011 · Progress in Neurobiology
  16. A Mathematical Model of the Kinetics of β-Amyloid Fibril Growth from the Denatured State
    Monica M. Pallitto, Regina M. Murphy · 2001 · Biophysical Journal
  17. Ca2+–Zn2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration
    John H. Weiss, Stefano Luca Sensi · 2000 · Trends in Neurosciences
  18. High‐resolution NMR studies of the zinc‐binding site of the Alzheimer's amyloid β‐peptide
    Danielsson, Jens, Pierattelli, Roberta, Banci, Lucia, Gräslund, Astrid · 2007 · The FEBS Journal
  19. Measuring zinc in living cells.
    K.R Gee, Zhuo Zhou, Dien Ton-That, Stefano Luca Sensi, John H. Weiss · 2002 · Cell Calcium
  20. Disruption of the Metallothionein-III Gene in Mice: Analysis of Brain Zinc, Behavior, and Neuron Vulnerability to Metals, Aging, and Seizures
    Jay C. Erickson, Gunther Hollopeter, STEVEN A. THOMAS, Glenda J. Froelick, Richard D. Palmiter · 1997 · Journal of Neuroscience
  21. Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease
    Peter John Crouch, Susan-Marie E. Harding, Anthony Robert White, James Camakaris, Ashley Ian Bush, Colin Louis Masters · 2007 · The International Journal of Biochemistry & Cell Biology
  22. New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
    Yoshiike, Yuji, Tanemura, Kentaro, Murayama, Ohoshi, Akagi, Takumi, Murayama, Miyuki, Sato, Shinji, Sun, Xiaoyan, Tanaka, Nobuo, Takashima, Akihiko · 2001 · Journal of Biological Chemistry
  23. Zinc takes the center stage: its paradoxical role in Alzheimer’s disease
    Math P. Cuajungco, Kyle Y. Faget · 2003 · Brain Research Reviews
  24. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer?s A? peptides
    Xudong Huang, Craig Atwood, Robert D. Moir, Mariana A. Hartshorn, Rudolph E. Tanzi, Ashley Ian Bush · 2004 · JBIC Journal of Biological Inorganic Chemistry
  25. Non-A.beta. Component of Alzheimer's Disease Amyloid (NAC) is Amyloidogenic
    Akihiko Iwai, Makoto Yoshimoto, Eliezer Masliah, Tsunao Saitoh · 1995 · Biochemistry
  26. Phosphorescent Sensor for Biological Mobile Zinc
    Youngmin You, Sumin Lee, Taehee Kim, Kei Ohkubo, Weon‐Sik Chae, Shunichi Fukuzumi, Gil‐Ja Jhon, Wonwoo Nam, Stephen J. Lippard · 2011 · Journal of the American Chemical Society
  27. A Role for Synaptic Zinc in Activity-Dependent Aβ Oligomer Formation and Accumulation at Excitatory Synapses
    Deshpande, Atul, Kawai, Hideki, Metherate, Raju, Glabe, Charles G., Busciglio, Jorge · 2009 · The Journal of Neuroscience
  28. Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
    Haythum Osama Tayeb, Hyun Duk Yang, Bruce Heimburger Price, Frank I. Tarazi · 2011 · Pharmacology & Therapeutics
  29. Free zinc ions outside a narrow concentration range are toxic to a variety of cells in vitro
    Rebecca A. Bozym, Fabrice Chimienti, Leonard J. Giblin, Gunter W Gross, Irina L. Korichneva, Yuan Li, Sarah Libert, Wolfgang Maret, Maryam Parviz, Christopher J. Frederickson et al. · 2010 · Experimental Biology and Medicine
  30. Reactive oxygen species and Alzheimer's disease
    Gerd Multhaup, Thomas Ruppert, Andrea Schlicksupp, Lars Hesse, Dirk Beher, Colin Louis Masters, Konrad Beyreuther · 1997 · Biochemical Pharmacology
  31. Interactions of Zn(ii) and Cu(ii) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity
    Vello Tõugu, Ann Tiiman, Peep Palumaa · 2011 · Metallomics
  32. Treatment of Alzheimer’s Disease with Clioquinol
    Regland, Björn, Lehmann, Werner, Abedini, Iraj, Blennow, Kaj, Jonsson, Michael, Karlsson, Ingvar, Sjögren, Magnus, Wallin, Anders, Xilinas, Michel, Gottfries, Carl-Gerhard · 2001 · Dementia and Geriatric Cognitive Disorders
  33. Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
    Sahni, Jasjeet Kaur, Doggui, Sihem, Ali, Javed, Baboota, Sanjula, Dao, Lé, Ramassamy, Charles · 2011 · Journal of Controlled Release
  34. Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons
    Masahiro Kawahara, Nelson J. Arispe, Yoichiro Kuroda, E. Rojas · 1997 · Biophysical Journal
  35. Review: Modulating Factors in Amyloid-β Fibril Formation
    JoAnne McLaurin, D.-S. Yang, Christopher M. Yip, Paul E. Fraser · 2000 · Journal of Structural Biology
  36. Metal Chelation as a Potential Therapy for Alzheimer's Disease
    Math P. Cuajungco, Kyle Y. Faget, Xudong Huang, Rudolph E. Tanzi, Ashley Ian Bush · 2000 · Annals of the New York Academy of Sciences
  37. Binding of zinc(II) and copper(II) to the full‐length Alzheimer’s amyloid‐β peptide
    Vello Tõugu, Ann Tiiman, Peep Palumaa · 2007 · Journal of Neurochemistry
  38. Physicochemical interactions of amyloid β-peptide with lipid bilayers
    Katsumi Matsuzaki · 2007 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  39. Magnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein
    Natalie Golts, Heather M. Snyder, Mark A. Frasier, Catherine M. Theisler, Peter Choi, Benjamin L. Wolozin · 2002 · Journal of Biological Chemistry
  40. History of Zinc as Related to Brain Function
    Harold H. Sandstead, Christopher J. Frederickson, James G. Penland · 2000 · Journal of Nutrition
  41. Copper(II) Binding to Amyloid-β Fibrils of Alzheimer’s Disease Reveals a Picomolar Affinity: Stoichiometry and Coordination Geometry Are Independent of Aβ Oligomeric Form
    Claire J. Sarell, Christopher D. Syme, Stephen E. J. Rigby, John H. Viles · 2009 · Biochemistry
  42. Alzheimer-like Changes in Microtubule-associated Protein Tau Induced by Sulfated Glycosaminoglycans
    Masato Hasegawa, R. Anthony Crowther, Ross Jakes, Michel Goedert · 1997 · Journal of Biological Chemistry
  43. Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
    Cioffi, Federica, Adam, Rayan Hassan Ibrahim, Broersen, Kerensa · 2019 · Journal of Alzheimer s Disease
  44. Soluble Amyloid Aβ-(1–40) Exists as a Stable Dimer at Low Concentrations
    William Garzon-Rodriguez, Marisa Sepulveda-Becerra, Saskia C. F. Milton, Charles G. Glabe · 1997 · Journal of Biological Chemistry
  45. What the evolution of the amyloid protein precursor supergene family tells us about its function
    Elizabeth Jane Coulson, Krzysztof Paliga, Konrad T. Beyreuther, Colin Louis Masters · 2000 · Neurochemistry International
  46. NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation.
    M Yoshimoto, Akihiko Iwai, David E. Kang, D A Otero, Yu Xia, Tsunao Saitoh · 1995 · Proceedings of the National Academy of Sciences
  47. Metal ions, Alzheimer's disease and chelation therapy
    Budimir, Ana · 2011 · Acta Pharmaceutica
  48. Novel -penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases
    Zhengrong Cui, Paul R. Lockman, Craig Atwood, Cathleen C. Hsu, Anshul Gupte, D ALLEN, Russell J. Mumper · 2004 · European Journal of Pharmaceutics and Biopharmaceutics
  49. Distinct Effects of Zn2+, Cu2+, Fe3+, and Al3+ on Amyloid-β Stability, Oligomerization, and Aggregation
    Wei-Ting Chen, Yi‐Hung Liao, Hui-Ming Yu, Irene Han-Juo Cheng, Yun‐Ru Chen · 2011 · Journal of Biological Chemistry
  50. Metal Ions, pH, and Cholesterol Regulate the Interactions of Alzheimer's Disease Amyloid-β Peptide with Membrane Lipid
    Cyril C. Curtain, Feda E. A. Ali, Danielle G. Smith, Ashley Ian Bush, Colin Louis Masters, Kevin Jeffrey Barnham · 2003 · Journal of Biological Chemistry
  51. Metallothioneins in Brain—The Role in Physiology and Pathology
    Michael Aschner, M. George Cherian, Curtis D. Klaassen, Richard D. Palmiter, Jay C. Erickson, Ashley Ian Bush · 1997 · Toxicology and Applied Pharmacology
  52. Substoichiometric Levels of Cu2+ Ions Accelerate the Kinetics of Fiber Formation and Promote Cell Toxicity of Amyloid-β from Alzheimer Disease
    Sarell, Claire J., Wilkinson, Shane R., Viles, John H. · 2010 · Journal of Biological Chemistry
  53. Effects of beta cell granule components on human islet amyloid polypeptide fibril formation
    Per Westermark, Zhan-Chun Li, Gunilla Torstensdotter Westermark, Arnold Leckström, Donald F. Steiner · 1996 · FEBS Letters
  54. Amyloid β Protein-(1–42) Forms Calcium-permeable, Zn2+-sensitive Channel
    Seung Keun Rhee, Arjan Pieter Quist, Ratneshwar Lal · 1998 · Journal of Biological Chemistry
  55. Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration
    Eduardo Rojas-Gutierrez, Guadalupe Muñoz‐Arenas, Samuel Treviño, Blanca Espinosa, Raúl Chávez, Karla Rojas, Gonzalo Flores, Alfonso Díaz, Jorge Guevara · 2017 · Synapse
  56. Antioxidant strategies for Alzheimer's disease
    Michael Grundman, Patrick Delaney · 2002 · Proceedings of The Nutrition Society
  57. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice
    Joo‐Yong Lee, Jonathan E. Friedman, Itzchak Angel, Alex Kozak, Jae‐Young Koh · 2004 · Neurobiology of Aging
  58. Metal swap between Zn7-metallothionein-3 and amyloid-β–Cu protects against amyloid-β toxicity
    Gabriele Meloni, Vanessa Sonois, Tamara Delaine, Luc Guilloreau, Audrey Gillet, Justin Teissié, Peter Faller, Milan Vašák · 2008 · Nature Chemical Biology
  59. Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis
    Germán Plascencia‐Villa, George L. Perry · 2020 · Antioxidants and Redox Signaling
  60. Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain
    Jan Näslund, Johan Thyberg, Lars O. Tjernberg, Christer Wernstedt, Anders R. Karlström, Nenad Bogdanović, Sam Gandy, Lars Lannfelt, Lars Y. Terenius, Christer Nordstedt · 1995 · Neuron
  61. Low Micromolar Zinc Accelerates the Fibrillization of Human Tau via Bridging of Cys-291 and Cys-322
    Zhongying Mo, Ying-Zhu Zhu, Haili Zhu, Jun-Bao Fan, Jie Chen, Yi Liang · 2009 · Journal of Biological Chemistry
  62. Effects of Dietary Supplementation of Carnosine on Mitochondrial Dysfunction, Amyloid Pathology, and Cognitive Deficits in 3xTg-AD Mice
    Carlo Corona, Valério Frazzini, Elena Silvestri, Rossano Lattanzio, Rossana La Sorda, Mauro Piantelli, Lorella M.T. Canzoniero, Domenico Ciavardelli, Enrico Rizzarelli, Stefano Luca Sensi · 2011 · PLoS ONE
  63. β-Amyloid (1–42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex
    Jin Hyeong Jhoo, Hyoung‐Chun Kim, Toshitaka Nabeshima, Kiyofumi Yamada, Eun‐Joo Shin, Wang‐Kee Jhoo, Woo Kyung Kim, Kee‐Seok Kang, Sangmee Ahn Jo, Jong Inn Woo · 2004 · Behavioural Brain Research
  64. Metal ions as modulators of protein conformation and misfolding in neurodegeneration
    Sónia S. Leal, Hugo M. Botelho, Cláudio M. Gomes · 2012 · Coordination Chemistry Reviews
  65. The Alzheimer’s therapeutic PBT2 promotes amyloid‐β degradation and GSK3 phosphorylation via a metal chaperone activity
    Peter John Crouch, Maria S. Savva, Lin Wai Hung, Paul S. Donnelly, Alexandra I. Mot, Sarah J. Parker, Mark A. Greenough, Irene Volitakis, Paul Anthony Adlard, Robert A. Cherny et al. · 2011 · Journal of Neurochemistry
  66. Determination of cadmium and zinc in Alzheimer's brain tissue using Inductively Coupled Plasma Mass Spectrometry
    Antonia Panayi, N. M. Spyrou, Bent Schack Iversen, M.A. White, P. Part · 2002 · Journal of the Neurological Sciences
  67. Zn(II)‐ and Cu(II)‐induced non‐fibrillar aggregates of amyloid‐β (1–42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators
    Tõugu, Vello, Karafin, Ann, Zovo, Kairit, Chung, Roger S., Howells, Claire, West, Adrian K., Palumaa, Peep · 2009 · Journal of Neurochemistry
  68. Metal-Catalyzed Oxidation of α-Synuclein in the Presence of Copper(II) and Hydrogen Peroxide
    Seung R. Paik, Hyun-Ju Shin, Ju‐Hyun Lee · 2000 · Archives of Biochemistry and Biophysics
  69. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors.
    R K Lee, Richard Jay Wurtman, A J Cox, Roger M. Nitsch · 1995 · Proceedings of the National Academy of Sciences
  70. Oxidative Stress Gated by Fenton and Haber Weiss Reactions and Its Association With Alzheimer’s Disease
    Kanti Das, Tushar, Wati, Mas Rina, Fatima-Shad, Kaneez · 2014 · Archives of Neuroscience
  71. Amyloid-β: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer’s disease
    Anatol Kontush · 2001 · Free Radical Biology and Medicine
  72. A brief overview of amyloids and Alzheimer's disease
    Sian‐Yang Ow, Dave E. Dunstan · 2014 · Protein Science
  73. Zinc Signal in Brain Diseases
    Stuart D Portbury, Paul Anthony Adlard · 2017 · International Journal of Molecular Sciences
  74. The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
    Travis J. A. Craddock, Jack A. Tuszyński, Deepak Chopra, Noel F. Casey, Lee E. Goldstein, Stuart R. Hameroff, Rudolph E. Tanzi · 2012 · PLoS ONE
  75. Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of β-amyloid protein
    Masahiro Kawahara, Midori Kato, Yoichiro Kuroda · 2001 · Brain Research Bulletin
  76. Carbonic anhydrase gating of attention: memory therapy and enhancement
    Miao‐Kun Sun, Daniel L. Alkon · 2002 · Trends in Pharmacological Sciences
  77. Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains
    Gorm Danscher, Knud Bjarne Jensen, Christopher J. Frederickson, Kåre Kemp, Arne Andreasen, Søren Juhl, Meredin Stoltenberg, Rivka Ravid · 1997 · Journal of Neuroscience Methods
  78. Zinc and Alzheimer's disease: is there a direct link?
    Math P. Cuajungco, Gordon J. Lees · 1997 · Brain Research Reviews
  79. How Do Membranes Initiate Alzheimer’s Disease? Formation of Toxic Amyloid Fibrils by the Amyloid β-Protein on Ganglioside Clusters
    Katsumi Matsuzaki · 2014 · Accounts of Chemical Research
  80. Zinc transporter 3 (ZnT3) and vesicular zinc in central nervous system function
    Brendan B. McAllister, Richard H. Dyck · 2017 · Neuroscience & Biobehavioral Reviews
  81. A cyanine-based fluorescent sensor for detecting endogenous zinc ions in live cells and organisms
    Zhiqian Guo, Gun-Hee Kim, Injae Shin, Juyoung Yoon · 2012 · Biomaterials
  82. Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer’s Disease
    Yong Hui Li, Qian Jiao, Huamin Xu, Xixun Du, Limin Shi, Fengju Jia, Hong Fu Jiang · 2017 · Frontiers in Molecular Neuroscience
  83. Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity
    Kent E. S. Matlack, Daniel F. Tardiff, Priyanka S. Narayan, Shusei Hamamichi, Kim A. Caldwell, Guy A. Caldwell, Susan Lee Lindquist · 2014 · Proceedings of the National Academy of Sciences
  84. Cu and Zn coordination to amyloid peptides: From fascinating chemistry to debated pathological relevance
    Elena Atrián‐Blasco, Paulina Gonzalez, Alice Santoro, Bruno Aliès, Peter Faller, Christelle Hureau · 2018 · Coordination Chemistry Reviews
  85. The amyloid precursor protein of Alzheimer’s disease and the Aβ peptide
    Storey, Roberto Cappai · 1999 · Neuropathology and Applied Neurobiology
  86. Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Aβ) of Alzheimer's disease
    Christopher D. Syme, John H. Viles · 2005 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  87. Cerium oxide caged metal chelator: anti-aggregation and anti-oxidation integrated H2O2-responsive controlled drug release for potential Alzheimer's disease treatment
    Meng Li, Peng Shi, Can Xu, Jinsong Ren, Xiaogang Qu · 2013 · Chemical Science
  88. Challenges Associated with Metal Chelation Therapy in Alzheimer's Disease
    Muralidhar L. Hegde, P. Bharathi, Anitha Suram, Chitra Venugopal, Ramya Jagannathan, Pankaj Poddar, Pullabhatla Srinivas, Kumar Sambamurti, K. S. Jagannatha Rao, Janez Ščančar et al. · 2009 · Journal of Alzheimer s Disease
  89. Imaging free zinc in synaptic terminals in live hippocampal slices
    Thomas Budde, Akwasi Minta, John A. White, Alan R. Kay · 1997 · Neuroscience
  90. Free Radicals in Human Health and Disease
    Umesh Chand Singh Yadav, Vibha Rani · 2014 · Springer eBooks
  91. Amyloid-β Binds Cu <sup>2+</sup> in a Mononuclear Metal Ion Binding Site
    Karr, Jesse W., Kaupp, Lauren J., Szalai, Veronika A. · 2004 · Journal of the American Chemical Society
  92. Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc
    Wolfgang Maret · 1995 · Neurochemistry International
  93. Metal Ion-dependent Effects of Clioquinol on the Fibril Growth of an Amyloid β Peptide
    Bakthisaran Raman, Tadato Ban, Kei‐ichi Yamaguchi, Miyo Sakai, Tomoji Kawai, Hironobu Naiki, Yuji Goto · 2005 · Journal of Biological Chemistry
  94. Zn2+ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation
    Taiji Tsunemi, Dimitri Krainc · 2013 · Human Molecular Genetics
  95. The Function and Regulation of Zinc in the Brain
    Rebecca F. Krall, Thanos Tzounopoulos, Elias Aizenman · 2021 · Neuroscience
  96. The Important Role of Zinc in Neurological Diseases
    Zhe Li, Yang Liu, Ruixue Wei, Voon Wee Yong, Mengzhou Xue · 2022 · Biomolecules
  97. Nanoparticle and other metal chelation therapeutics in Alzheimer disease
    Gang Liu, Matthew R. Garrett, Ping Men, Xiongwei Zhu, George L. Perry, Mark A. Smith · 2005 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  98. Synthesis, Characterization, and Metal Coordinating Ability of Multifunctional Carbohydrate-Containing Compounds for Alzheimer's Therapy
    Storr, Tim, Merkel, Michael, Song-Zhao, George X., Scott, Lauren E., Green, David E., Bowen, Meryn L., Thompson, Katherine H., Patrick, Brian O., Schugar, Harvey J., Orvig, Chris · 2007 · Journal of the American Chemical Society
  99. Amyloid β‐protein (Aβ)1–40 protects neurons from damage induced by Aβ1–42 in culture and in rat brain
    Kun Zou, Dae Sung Kim, Atsuko Kakio, Kyunghee Byun, Jian‐Sheng Gong, Jae Woo Kim, Myeung Ju Kim, Naoya Sawamura, Sei‐ichi Nishimoto, Katsumi Matsuzaki et al. · 2003 · Journal of Neurochemistry
  100. Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid
    Dorothea Altschul, Lenore J. Launer, Paul Anthony Adlard, Robert A. Cherny, Andrew Tsatsanis, Irene Volitakis, Kaj Blennow, Helen Petrovitch, Lon R. White, Ashley Ian Bush · 2007 · Neurobiology of Aging